The Gross Margin of AptaBio Therapeutics Inc (293780.KQ) is 24.24%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
| Date | Value |
|---|---|
| 2023-12-31 | 24.24% |
| 2022-12-31 | 76.94% |